F-star Therapeutics, Inc. (FSTX) Misses Q2 EPS by 29c
Tweet
Share
E-mailGet Alerts FSTX Hot Sheet
Join SI Premium – FREE
F-star Therapeutics, Inc. (NASDAQ: FSTX) reported Q2 EPS of ($0.88), $0.29 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on F-star Therapeutics, Inc. (FSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Amundi surges as on bigger-than-expected profit, record AUM
- Nomura Holdings (NMR) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
